- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT07949526
Compressive Dressing and Pharyngocutaneous Fistula After Primary Total Laryngectomy (TIGHT)
Impact of Compressive Dressing on the Risk of Pharyngocutaneous Fistula After Primary Total Laryngectomy: A Multicenter Retrospective Observational Study
Pharyngocutaneous fistula (PCF) is one of the most feared complications after total laryngectomy. A compressive neck dressing is often applied after surgery to try to prevent it, but there is no consensus on whether it works or how long it should be kept, and practice varies widely between centers. This multicenter, retrospective, observational study compares the rate of PCF in adult patients with laryngeal squamous cell carcinoma who underwent primary total laryngectomy with direct closure of the hypopharyngeal mucosa and who did or did not receive a postoperative compressive dressing. It also examines whether the duration of the dressing affects the risk of fistula and how fistulas were managed in the two groups. All data are collected from existing medical records; no additional treatment or examination is performed.
Přehled studie
Postavení
Intervence / Léčba
Detailní popis
PCF occurs in about 14% of primary total laryngectomies and about 28% of salvage procedures. It is associated with prolonged hospital stay, higher costs, delayed adjuvant treatment, and further complications. No study has directly compared patients managed with and without a postoperative compressive dressing.
This is a non-profit, multicenter, national, retrospective observational study coordinated by IRCCS Azienda Ospedaliero-Universitaria di Bologna. Consecutive patients who underwent primary total laryngectomy from January 1, 2014 to the study start date are included. All patients were treated according to routine clinical practice at each center. Patients are divided into two groups according to postoperative management: compressive dressing of the cervical region over the neopharyngeal suture (Group A) or no compressive dressing (Group B).
Data are extracted from medical records and entered in pseudonymized form in an electronic case report form (REDCap). Collected variables include demographics, smoking and alcohol use, comorbidities, preoperative laboratory values and inflammatory indices, tumor site and clinical stage, surgical details (neck dissection, thyroidectomy, pharyngeal closure technique, salivary stent, primary voice prosthesis), postoperative antibiotic protocol, time to oral feeding, and fistula characteristics and management.
The planned sample size is 950 patients (475 per group), which provides 80% power to detect a 6.0% difference in fistula rate between groups, assuming a baseline rate of 14.3% in the group without compressive dressing, using a two-sided Fisher's exact test with alpha 0.05. The primary outcome will be analyzed with Fisher's exact test. Secondary outcomes will be analyzed with logistic and linear regression. Confounding will be addressed with propensity score matching, inverse probability weighting, or covariate adjustment, as appropriate.
Typ studie
Zápis (Odhadovaný)
Kontakty a umístění
Studijní kontakt
- Jméno: Edoardo Serafini, MD, Medical Degree
- Telefonní číslo: +39 051 2145263
- E-mail: edoardo.serafini3@unibo.it
Studijní místa
-
-
-
Bergamo, Itálie
- Nábor
- ASST Papa Giovanni XXIII
-
Kontakt:
- Giovanni Danesi, Medical Degree
- Telefonní číslo: +39 035 2674398
- E-mail: gdanesi@asst-pg23.it
-
Bologna, Itálie
- Nábor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola
-
Kontakt:
- Edoardo Serafini, Medical Degree
- Telefonní číslo: +39 051 2145263
-
Bologna, Itálie
- Nábor
- Ospedale Maggiore Carlo Alberto Pizzardi
-
Kontakt:
- Luca Amorosa, Medical Degree
- Telefonní číslo: +39 051 6478365
- E-mail: luca.amorosa@ausl.bologna.it
-
Bolzano, Itálie
- Nábor
- Ospedale Centrale di Bolzano
-
Kontakt:
- Luca Calabrese, medical degree
- Telefonní číslo: +39 0471 438641
- E-mail: orlbz@sabes.it
-
Brescia, Itálie
- Nábor
- ASST degli Spedali Civili di Brescia
-
Kontakt:
- Cesare Piazza, Medical Degree
- Telefonní číslo: +39 030 3995319
- E-mail: cesare.piazza@unibs.it
-
Candiolo, Itálie
- Nábor
- IRCCS Istituto di Candiolo - Fondazione del Piemonte per l'Oncologia
-
Kontakt:
- Stefano Bondi, Medical Degree
- Telefonní číslo: +39 011 9933405
- E-mail: stefano.bondi@ircc.it
-
Cesena, Itálie
- Nábor
- Ospedale M. Bufalini
-
Kontakt:
- Massimo Magnani, Medical Degree
- Telefonní číslo: +39 0541 933458
- E-mail: massimo.magnani@auslromagna.it
-
Florence, Itálie
- Nábor
- Azienda Ospedaliero-Universitaria Careggi
-
Kontakt:
- Giandomenico Maggiore, Medical Degree
- Telefonní číslo: +39 055 7942000
-
Forlì, Itálie
- Nábor
- Ospedale G.B. Morgagni - L. Pierantoni
-
Kontakt:
- Andrea De Vito, Medical Degree
- Telefonní číslo: +39 0543 73651
- E-mail: andrea.devito@auslromagna.it
-
Milan, Itálie
- Nábor
- Istituto Nazionale dei Tumori
-
Kontakt:
- Alberto Deganello, Medical Degree
- E-mail: alberto.deganello@unimi.it
-
Milan, Itálie
- Nábor
- Ospedale San Raffaele
-
Kontakt:
- Andrea Galli
- Telefonní číslo: +390226438446
- E-mail: salerno.emilio@hsr.it
-
Kontakt:
- Mario Bussi, medical degree
- E-mail: bussi.mario@hsr.it
-
Modena, Itálie
- Nábor
- Azienda Ospedaliero-Universitaria Policlinico di Modena
-
Kontakt:
- Daniele Marchioni, Medical Degree
- Telefonní číslo: +39 059 4222402
- E-mail: daniele.marchioni@unimore.it
-
Naples, Itálie
- Nábor
- AORN Ospedale Cardarelli
-
Kontakt:
- FIlippo Ricciardelli, Medical Degree
- Telefonní číslo: +39 081 7474035
- E-mail: filippo.ricciardiello@aocardarelli.it
-
Padova, Itálie
- Nábor
- Azienda Ospedale-Università di Padova
-
Kontakt:
- Piero Nicolai, Medical Degree
- Telefonní číslo: +39 049 8212024
- E-mail: piero.nicolai@unipd.it
-
Pavia, Itálie
- Nábor
- Fondazione IRCCS Policlinico San Matteo
-
Kontakt:
- Marco Benazzo, Medical Degree
- E-mail: marco.benazzo@unipv.it
-
Pescara, Itálie
- Nábor
- Ospedale Santo Spirito
-
Kontakt:
- Claudio D Caporale, Medical Degree
- Telefonní číslo: +39 085 4252682
- E-mail: claudiodonadio.caporale@asl.pe.it
-
Ravenna, Itálie
- Nábor
- Ospedale Santa Maria delle Croci
-
Kontakt:
- Ignacio J Fernandez, Medical Degree
- E-mail: ignacio.fernandez4@unibo.it
-
Reggio Emilia, Itálie
- Nábor
- Arcispedale Santa Maria Nuova
-
Kontakt:
- Angelo Ghidini, Medical Degree
- Telefonní číslo: +39 0522 296111
- E-mail: angelo.ghidini@ausl.re.it
-
Rimini, Itálie
- Nábor
- Ospedale Infermi
-
Kontakt:
- Marco Trebbi, Medical Degree
- E-mail: marco.trebbi@auslromagna.it
-
Roma, Itálie
- Nábor
- Fondazione Policlinico Universitario Agostino Gemelli
-
Kontakt:
- Gaetano Paludetti, Medical Degree
- E-mail: gaetano.paludetti@policlinicogemelli.it
-
Roma, Itálie
- Nábor
- Ospedale Fatebenefratelli Isola Tiberina - Gemelli Isola
-
Kontakt:
- Marco Radici, Medical Degree
- Telefonní číslo: +39 06 6837297
- E-mail: marco.radici@fondazionefatebenefratelli.it
-
Roma, Itálie
- Nábor
- Policlinico Umberto I (Sapienza)
-
Kontakt:
- Marco De Vincentis, Medical Degree
- E-mail: marco.devincentiis@uniroma1.it
-
Torino, Itálie
- Nábor
- AOU Città della Salute e della Scienza (Molinette)
-
Kontakt:
- Giancarlo Pecorari, Medical Degree
- Telefonní číslo: +39 011 6709583
- E-mail: giancarlo.pecorari@unito.it
-
Trieste, Itálie
- Nábor
- Ospedale di Cattinara
-
Kontakt:
- Giancarlo Tirelli, Medical Degree
- Telefonní číslo: +39 040 3994933
- E-mail: tirellig@units.it
-
Verona, Itálie
- Nábor
- Azienda Ospedaliera Universitaria Integrata di Verona
-
Kontakt:
- Luca Sacchetto, Medical Degree
- Telefonní číslo: +39 045 8127538
- E-mail: luca.sacchetto@univr.it
-
Vittorio Veneto, Itálie
- Nábor
- Ospedale di Vittorio Veneto - ULSS 2 Marca Trevigiana
-
Kontakt:
- Andy Bertolin, Medical Degree
- Telefonní číslo: +39 0438 665231
- E-mail: andy.bertolin@aulss2.veneto.it
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Metoda odběru vzorků
Studijní populace
Consecutive adult patients with squamous cell carcinoma of the larynx who underwent primary total laryngectomy with direct closure of the hypopharyngeal mucosa at the participating Italian otolaryngology centers from January 1, 2014 to the study start date.
Popis
Inclusion Criteria:
- Squamous cell carcinoma of the larynx treated with primary total laryngectomy
- Primary closure of the hypopharyngeal mucosa
- Age 18 years or older
- Informed consent to study participation and to personal data processing
- Availability of data on comorbidities, laboratory parameters, and postoperative management
Exclusion Criteria:
- Salvage total laryngectomy
- Previous radiotherapy or chemoradiotherapy to the head and neck
- Previous open surgery of the pharyngolaryngeal region
- Reconstruction with a free or pedicled flap (inlay or onlay)
Studijní plán
Jak je studie koncipována?
Detaily designu
- Observační modely: COHORT
- Časové perspektivy: RETROSPECTIVE
Kohorty a intervence
Skupina / kohorta |
Intervence / Léčba |
|---|---|
|
Compressive dressing (Group A)
Patients who received a postoperative compressive dressing of the cervical region over the neopharyngeal suture after primary total laryngectomy, according to routine clinical practice at the treating center. |
Postoperative compressive dressing applied to the cervical region over the neopharyngeal suture. This is an exposure observed in routine clinical practice; it is not assigned by the study. |
|
No compressive dressing (Group B)
Patients who did not receive a postoperative compressive dressing after primary total laryngectomy, according to routine clinical practice at the treating center. |
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Incidence of pharyngocutaneous fistula
Časové okno: During the postoperative hospital stay (from surgery to discharge), up to 60 days
|
Number and percentage of patients who develop a pharyngocutaneous fistula in each group (compressive dressing vs no compressive dressing). |
During the postoperative hospital stay (from surgery to discharge), up to 60 days
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Incidence of pharyngocutaneous fistula by duration of compressive dressing
Časové okno: During the postoperative hospital stay (from surgery to discharge), up to 60 days
|
Number and percentage of patients in Group A who develop a pharyngocutaneous fistula, stratified by duration of the compressive dressing (days). |
During the postoperative hospital stay (from surgery to discharge), up to 60 days
|
|
Time to onset of pharyngocutaneous fistula
Časové okno: During the postoperative hospital stay (from surgery to discharge), up to 60 days
|
Number of days from surgery to diagnosis of pharyngocutaneous fistula in each group. |
During the postoperative hospital stay (from surgery to discharge), up to 60 days
|
|
Type of management of pharyngocutaneous fistula
Časové okno: During the postoperative hospital stay (from surgery to discharge), up to 60 days
|
Number and percentage of patients with fistula managed conservatively (compressive dressing) or surgically in each group. |
During the postoperative hospital stay (from surgery to discharge), up to 60 days
|
|
Resolution of pharyngocutaneous fistula
Časové okno: During the postoperative hospital stay (from surgery to discharge), up to 60 days
|
Number and percentage of patients whose fistula resolved, by initial group and type of management. |
During the postoperative hospital stay (from surgery to discharge), up to 60 days
|
|
Time to resolution of pharyngocutaneous fistula
Časové okno: During the postoperative hospital stay (from surgery to discharge), up to 60 days
|
Number of days from diagnosis to resolution of the fistula, by initial group and type of management. |
During the postoperative hospital stay (from surgery to discharge), up to 60 days
|
Spolupracovníci a vyšetřovatelé
Sponzor
Vyšetřovatelé
- Vrchní vyšetřovatel: Edoardo Serafini, Medical Degree, IRCCS Azienda Ospedaliero-Universitaria di Bologna
Publikace a užitečné odkazy
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Odhadovaný)
Dokončení studie (Odhadovaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Další relevantní podmínky MeSH
- Patologické procesy
- Novotvary podle místa
- Novotvary
- Nemoci dýchacích cest
- Novotvary podle histologického typu
- Novotvary hlavy a krku
- Novotvary, žlázové a epiteliální
- Novotvary dýchacího traktu
- Karcinom
- Otorinolaryngologická onemocnění
- Otorinolaryngologické novotvary
- Karcinom, skvamózní buňky
- Nemoci hrtanu
- Patologické stavy, příznaky a symptomy
- Spinocelulární karcinom hlavy a krku
- Novotvary hrtanu
- Pooperační komplikace
Další identifikační čísla studie
- 162/2025/Oss/AOUBo
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Popis plánu IPD
De-identified individual participant data underlying the published results will be made available upon reasonable request to the Principal Investigator.
Časový rámec sdílení IPD
After publication of the study results in a peer-reviewed journal.
Kritéria přístupu pro sdílení IPD
Data will be shared with researchers who submit a motivated request to the Principal Investigator of the coordinating center (IRCCS Azienda Ospedaliero-Universitaria di Bologna).
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .